Cholera Vaccine (Oral Route) Market Report

China Cholera Vaccine (Oral Route) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 23, 2022
  • PAGES：195
  • REPORT CODE：GMM1123794
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Cholera Vaccine (Oral Route) market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Cholera Vaccine (Oral Route) market. Detailed analysis of key players, along with key growth strategies adopted by Cholera Vaccine (Oral Route) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • EuBiologics

    • Valneva

    • Sanofi

    • PaxVax

    By Type:

    • Shanchol

    • Dukoral

    • Vaxchora

    • Others

    By End-User:

    • Hospital

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cholera Vaccine (Oral Route) Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2016 to 2027

    • 1.3.2 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2016 to 2027

    • 1.3.3 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2016 to 2027

    • 1.3.4 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.2 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Research & Academic Laboratories from 2016 to 2027

    • 1.4.3 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2016 to 2027

    • 1.4.4 China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Cholera Vaccine (Oral Route) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cholera Vaccine (Oral Route) by Major Types

    • 3.4.1 Market Size and Growth Rate of Shanchol

    • 3.4.2 Market Size and Growth Rate of Dukoral

    • 3.4.3 Market Size and Growth Rate of Vaxchora

    • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Cholera Vaccine (Oral Route) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cholera Vaccine (Oral Route) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Hospital

    • 4.4.2 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Research & Academic Laboratories

    • 4.4.3 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Pharmaceutical & Biotechnology Companies

    • 4.4.4 Market Size and Growth Rate of Cholera Vaccine (Oral Route) in Others

    5 Market Analysis by Regions

    • 5.1 China Cholera Vaccine (Oral Route) Production Analysis by Regions

    • 5.2 China Cholera Vaccine (Oral Route) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Cholera Vaccine (Oral Route) Landscape Analysis

    • 6.1 North China Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 6.2 North China Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    7 Central China Cholera Vaccine (Oral Route) Landscape Analysis

    • 7.1 Central China Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 7.2 Central China Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    8 South China Cholera Vaccine (Oral Route) Landscape Analysis

    • 8.1 South China Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 8.2 South China Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    9 East China Cholera Vaccine (Oral Route) Landscape Analysis

    • 9.1 East China Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 9.2 East China Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    10 Northeast China Cholera Vaccine (Oral Route) Landscape Analysis

    • 10.1 Northeast China Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 10.2 Northeast China Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    11 Southwest China Cholera Vaccine (Oral Route) Landscape Analysis

    • 11.1 Southwest China Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 11.2 Southwest China Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    12 Northwest China Cholera Vaccine (Oral Route) Landscape Analysis

    • 12.1 Northwest China Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 12.2 Northwest China Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 EuBiologics

      • 13.1.1 EuBiologics Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Valneva

      • 13.2.1 Valneva Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Sanofi

      • 13.3.1 Sanofi Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 PaxVax

      • 13.4.1 PaxVax Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Shanchol from 2016 to 2027

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Dukoral from 2016 to 2027

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Vaxchora from 2016 to 2027

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Research & Academic Laboratories from 2016 to 2027

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2016 to 2027

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Cholera Vaccine (Oral Route) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Cholera Vaccine (Oral Route)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cholera Vaccine (Oral Route) by Different Types from 2016 to 2027

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Shanchol

    • Figure Market Size and Growth Rate of Dukoral

    • Figure Market Size and Growth Rate of Vaxchora

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Cholera Vaccine (Oral Route) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Research & Academic Laboratories

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Others

    • Table China Cholera Vaccine (Oral Route) Production by Regions

    • Table China Cholera Vaccine (Oral Route) Production Share by Regions

    • Figure China Cholera Vaccine (Oral Route) Production Share by Regions in 2016

    • Figure China Cholera Vaccine (Oral Route) Production Share by Regions in 2021

    • Figure China Cholera Vaccine (Oral Route) Production Share by Regions in 2027

    • Table China Cholera Vaccine (Oral Route) Consumption by Regions

    • Table China Cholera Vaccine (Oral Route) Consumption Share by Regions

    • Figure China Cholera Vaccine (Oral Route) Consumption Share by Regions in 2016

    • Figure China Cholera Vaccine (Oral Route) Consumption Share by Regions in 2021

    • Figure China Cholera Vaccine (Oral Route) Consumption Share by Regions in 2027

    • Table North China Cholera Vaccine (Oral Route) Consumption by Types from 2016 to 2027

    • Table North China Cholera Vaccine (Oral Route) Consumption Share by Types from 2016 to 2027

    • Figure North China Cholera Vaccine (Oral Route) Consumption Share by Types in 2016

    • Figure North China Cholera Vaccine (Oral Route) Consumption Share by Types in 2021

    • Figure North China Cholera Vaccine (Oral Route) Consumption Share by Types in 2027

    • Table North China Cholera Vaccine (Oral Route) Consumption by End-Users from 2016 to 2027

    • Table North China Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2016 to 2027

    • Figure North China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2016

    • Figure North China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2021

    • Figure North China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2027

    • Table Central China Cholera Vaccine (Oral Route) Consumption by Types from 2016 to 2027

    • Table Central China Cholera Vaccine (Oral Route) Consumption Share by Types from 2016 to 2027

    • Figure Central China Cholera Vaccine (Oral Route) Consumption Share by Types in 2016

    • Figure Central China Cholera Vaccine (Oral Route) Consumption Share by Types in 2021

    • Figure Central China Cholera Vaccine (Oral Route) Consumption Share by Types in 2027

    • Table Central China Cholera Vaccine (Oral Route) Consumption by End-Users from 2016 to 2027

    • Table Central China Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2016

    • Figure Central China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2021

    • Figure Central China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2027

    • Table South China Cholera Vaccine (Oral Route) Consumption by Types from 2016 to 2027

    • Table South China Cholera Vaccine (Oral Route) Consumption Share by Types from 2016 to 2027

    • Figure South China Cholera Vaccine (Oral Route) Consumption Share by Types in 2016

    • Figure South China Cholera Vaccine (Oral Route) Consumption Share by Types in 2021

    • Figure South China Cholera Vaccine (Oral Route) Consumption Share by Types in 2027

    • Table South China Cholera Vaccine (Oral Route) Consumption by End-Users from 2016 to 2027

    • Table South China Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2016 to 2027

    • Figure South China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2016

    • Figure South China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2021

    • Figure South China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2027

    • Table East China Cholera Vaccine (Oral Route) Consumption by Types from 2016 to 2027

    • Table East China Cholera Vaccine (Oral Route) Consumption Share by Types from 2016 to 2027

    • Figure East China Cholera Vaccine (Oral Route) Consumption Share by Types in 2016

    • Figure East China Cholera Vaccine (Oral Route) Consumption Share by Types in 2021

    • Figure East China Cholera Vaccine (Oral Route) Consumption Share by Types in 2027

    • Table East China Cholera Vaccine (Oral Route) Consumption by End-Users from 2016 to 2027

    • Table East China Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2016 to 2027

    • Figure East China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2016

    • Figure East China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2021

    • Figure East China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2027

    • Table Northeast China Cholera Vaccine (Oral Route) Consumption by Types from 2016 to 2027

    • Table Northeast China Cholera Vaccine (Oral Route) Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Cholera Vaccine (Oral Route) Consumption Share by Types in 2016

    • Figure Northeast China Cholera Vaccine (Oral Route) Consumption Share by Types in 2021

    • Figure Northeast China Cholera Vaccine (Oral Route) Consumption Share by Types in 2027

    • Table Northeast China Cholera Vaccine (Oral Route) Consumption by End-Users from 2016 to 2027

    • Table Northeast China Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2016

    • Figure Northeast China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2021

    • Figure Northeast China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2027

    • Table Southwest China Cholera Vaccine (Oral Route) Consumption by Types from 2016 to 2027

    • Table Southwest China Cholera Vaccine (Oral Route) Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Cholera Vaccine (Oral Route) Consumption Share by Types in 2016

    • Figure Southwest China Cholera Vaccine (Oral Route) Consumption Share by Types in 2021

    • Figure Southwest China Cholera Vaccine (Oral Route) Consumption Share by Types in 2027

    • Table Southwest China Cholera Vaccine (Oral Route) Consumption by End-Users from 2016 to 2027

    • Table Southwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2016

    • Figure Southwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2021

    • Figure Southwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2027

    • Table Northwest China Cholera Vaccine (Oral Route) Consumption by Types from 2016 to 2027

    • Table Northwest China Cholera Vaccine (Oral Route) Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Cholera Vaccine (Oral Route) Consumption Share by Types in 2016

    • Figure Northwest China Cholera Vaccine (Oral Route) Consumption Share by Types in 2021

    • Figure Northwest China Cholera Vaccine (Oral Route) Consumption Share by Types in 2027

    • Table Northwest China Cholera Vaccine (Oral Route) Consumption by End-Users from 2016 to 2027

    • Table Northwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2016

    • Figure Northwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2021

    • Figure Northwest China Cholera Vaccine (Oral Route) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of EuBiologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EuBiologics

    • Figure Sales and Growth Rate Analysis of EuBiologics

    • Figure Revenue and Market Share Analysis of EuBiologics

    • Table Product and Service Introduction of EuBiologics

    • Table Company Profile and Development Status of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US